The role of coxsackie B viruses in heart disease in New Zealand.
Sera from 622 patients received in a 20-month period were examined for coxsackie B neutralising antibody to serotypes 1--6. Two hundred and thirty-four of the total 622 were patients with a cardiac symptomatology, and 388 formed a comparable group of non-cardiac cases. There were 141 (60 percent) seropositive patients in the cardiac group, 34 percent and 29 percent of which respectively had antibody to B4 and B2. The clinical data provided on these 141 patients indicated that 33 (23 percent) had acute myocarditis, and 59 (42 percent) had acute pericarditis; 41 (29 percent) were recorded as having acute pleurodynia or Bronholm disease while eight (6 percent) had other indications of cardiac disease. Amongst the cardiac patients the highest prevalence of seropositivity was found in the 20--39 age group and 67 percent of these were males.
D000208:Acute Disease; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D029822:Enterovirus B, Human / Q000276:immunology*; D005260:Female; D006331:Heart Diseases / Q000209:etiology* / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000209:etiology / Q000276:immunology; D010493:Pericarditis / Q000209:etiology / Q000276:immunology; D011000:Pleurodynia, Epidemic / Q000209:etiology / Q000276:immunology
D000914:Antibodies, Viral